Copper(II) complexes of a nonsteroidal anti-inflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-mu-(2-[3-(trifluoromethyl) phenyl]aminonicotinato)bis(dimethylsulfoxide)-dicopper(II) complex at 190 K. Anti-inflammatory propertie

scientific article published on 01 July 1999

Copper(II) complexes of a nonsteroidal anti-inflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-mu-(2-[3-(trifluoromethyl) phenyl]aminonicotinato)bis(dimethylsulfoxide)-dicopper(II) complex at 190 K. Anti-inflammatory propertie is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0162-0134(99)00104-X
P698PubMed publication ID10530003

P2093author name stringJ J Girerd
F T Greenaway
N H Dung
B Viossat
E Riviere
G Morgant
J C Daran
M Roch Arveiller
X Labouze
P2860cites workInteraction of Cu(II) 3,5-diisopropylsalicylate with human serum albumin--an evaluation of spectroscopic dataQ32134527
The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytesQ34480543
Oxygen Radical Scavenger Activity, EPR, NMR, Molecular Mechanics and Extended-Hückel Molecular Orbital Investigation of the Bis(Piroxicam)Copper(II) ComplexQ36626350
Schizophrenia, Alzheimer's disease, and anti-inflammatory agentsQ41018831
Inflammation and Alzheimer diseaseQ41167374
Non-steroidal anti-inflammatory drug-copper complex modulation of polymorphonuclear leukocyte migrationQ43431739
Copper chelates as possible active forms of the antiarthritic agentsQ43606538
Structure of Cu2(indomethacin)4 and the reaction with superoxide in aprotic systemsQ50942813
Synthesis and characterization of tetrakis-μ-2-[(2,6dichlorophenyl) amino] benzeneacetodiaquodicopper(II) dihydrate and tetrakis-μ-2-[(2,6dichlorophenyl)amino]benzeneaceto dimethylformamidodicopper(II)Q60609939
Completion and refinement of crystal structures withSIR92Q63442948
Effects of acute prednisolone administration on plasma and liver copper in rats with adjuvant arthritisQ67535853
Effects of some non-steroidal anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidative metabolismQ68495362
The effect of inhibition of both diacylglycerol metabolism and phospholipase A2 activity on superoxide generation by human neutrophilsQ69831798
Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trialQ69927046
Bis(3,5-diisopropylsalicylato)copper(II), a potent radioprotectant with superoxide dismutase mimetic activityQ70678942
Copper(II) interactions with nonsteroidal antiinflammatory agents. I. Salicylic acid and acetylsalicylic acidQ72593703
P433issue1
P304page(s)19-27
P577publication date1999-07-01
P1433published inJournal of Inorganic BiochemistryQ3186919
P1476titleCopper(II) complexes of a nonsteroidal anti-inflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-mu-(2-[3-(trifluoromethyl) phenyl]aminonicotinato)bis(dimethylsulfoxide)-dicopper(II) complex at 190 K. Anti-inflammatory properties
P478volume76

Reverse relations

cites work (P2860)
Q59481265Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
Q28196882Low-temperature (180 K) crystal structure, electron paramagnetic resonance spectroscopy, and propitious anticonvulsant activities of CuII2(aspirinate)4(DMF)2 and other CuII2(aspirinate)4 chelates
Q72991414Low-temperature crystal structures of tetrakis-mu-3,5-diisopropylsalicylatobis-dimethylformamidodico pper(II) and tetrakis-mu-3,5-diisopropylsalicylatobis-diethyletheratodicopp er(II) and their role in modulating polymorphonuclear leukocyte activity
Q56058325Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Metal Complexes and Their Effect at the Cellular Level

Search more.